Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
ISIS-GCGRRx
Also known as: formerly ISIS-GCGR
print preview
bookmark
share with colleague
General Information
Company
Isis Pharmaceuticals Inc.
Description
Antisense inhibitor targeting glucagon receptor (GCGR)
Molecular Target
Glucagon receptor (GCGR)
Mechanism of Action
Antisense therapy
Latest Stage of Development
Phase I
Indication
Diabetes
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy